loading
Schlusskurs vom Vortag:
$2.05
Offen:
$2.04
24-Stunden-Volumen:
275.33K
Relative Volume:
0.17
Marktkapitalisierung:
$68.29M
Einnahmen:
$3.04M
Nettoeinkommen (Verlust:
$-33.97M
KGV:
-1.4695
EPS:
-1.38
Netto-Cashflow:
$-52.47M
1W Leistung:
-13.66%
1M Leistung:
-21.05%
6M Leistung:
-60.53%
1J Leistung:
+0.45%
1-Tages-Spanne:
Value
$2.01
$2.08
1-Wochen-Bereich:
Value
$2.00
$2.37
52-Wochen-Spanne:
Value
$1.90
$8.75

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
Firmenname
Rani Therapeutics Holdings Inc
Name
Telefon
(408) 457-3700
Name
Adresse
2051 RINGWOOD AVENUE, SAN JOSE
Name
Mitarbeiter
140
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-08
Name
Neueste SEC-Einreichungen
Name
RANI's Discussions on Twitter

Vergleichen Sie RANI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
RANI 2.025 68.29M 3.04M -33.97M -52.47M -1.38
VRTX 450.35 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.65 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.59 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.57 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.09 24.89B 3.30B -501.07M 1.03B 11.54

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-04-17 Fortgesetzt BTIG Research Buy
2022-10-11 Eingeleitet UBS Buy
2022-07-27 Eingeleitet H.C. Wainwright Buy
2022-06-13 Eingeleitet Wedbush Outperform

Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten

pulisher
Nov 20, 2024

RANI: Third Quarter Update - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

HC Wainwright Reiterates "Buy" Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Rani Therapeutics Advances in Biotherapeutics Market - TipRanks

Nov 18, 2024
pulisher
Nov 15, 2024

Rani Therapeutics Holdings Inc (RANI) Quarterly 10-Q Report - Quartz

Nov 15, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Rani Therapeutics H - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Rani Therapeutics Slashes Q3 Loss by 31%, Secures $20M Funding for GLP-1 Development | RANI Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 07, 2024

Rani Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 07, 2024
pulisher
Nov 03, 2024

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) PT at $11.71 - Defense World

Nov 03, 2024
pulisher
Oct 31, 2024

Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $11.71 - MarketBeat

Oct 31, 2024
pulisher
Oct 25, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Sees Significant Growth in Short Interest - MarketBeat

Oct 25, 2024
pulisher
Oct 23, 2024

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch - Simply Wall St

Oct 23, 2024
pulisher
Oct 22, 2024

RANI: New Triagonist Data in Weight Loss - Zacks Small Cap Research

Oct 22, 2024
pulisher
Oct 19, 2024

Rani Therapeutics shares hold buy rating on positive preclinical data By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

Rani Therapeutics stock gets positive outlook from H.C. Wainwright after novel obesity candidate progress - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.75% - MSN

Oct 19, 2024
pulisher
Oct 18, 2024

Rani Therapeutics shares hold buy rating on positive preclinical data - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Rani Therapeutics (NASDAQ:RANI) Receives "Buy" Rating from HC Wainwright - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Rani Therapeutics reports promising obesity treatment delivery By Investing.com - Investing.com South Africa

Oct 18, 2024
pulisher
Oct 18, 2024

Rani therapeutics sees $10 million in stock sales by major investors By Investing.com - Investing.com

Oct 18, 2024
pulisher
Oct 17, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Major Shareholder South Cone Investments Limited Sells 3,829,360 Shares - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75% - MSN

Oct 17, 2024
pulisher
Oct 17, 2024

Rani Therapeutics reports promising obesity treatment delivery - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Rani Therapeutics Announces New Preclinical Pharmacokinetic - GlobeNewswire

Oct 17, 2024
pulisher
Oct 17, 2024

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist - The Manila Times

Oct 17, 2024
pulisher
Oct 17, 2024

Rani Therapeutics (RANI) Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist - StreetInsider.com

Oct 17, 2024
pulisher
Oct 16, 2024

Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering - MSN

Oct 16, 2024
pulisher
Oct 16, 2024

Recent Insider Activity Could Benefit Comcast Corp (CMCSA) - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Market Momentum: Rani Therapeutics Holdings Inc (RANI) Registers a -33.33 Decrease, Closing at 2.12 - The Dwinnex

Oct 16, 2024
pulisher
Oct 16, 2024

There is no doubt that Rani Therapeutics Holdings Inc (RANI) ticks all the boxes. - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

An Analysis of Avidity Biosciences Inc (RNA)’s Potential Price Growth - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Form 424B5 Rani Therapeutics Holdin - StreetInsider.com

Oct 16, 2024
pulisher
Oct 15, 2024

United States shares lower at close of trade; Dow Jones Industrial Average down 0.75% - MSN

Oct 15, 2024
pulisher
Oct 15, 2024

Why Rani Therapeutics Shares Are Down 23% Today - Benzinga

Oct 15, 2024
pulisher
Oct 15, 2024

“Peraso Inc. (NASDAQ: PRSO) Revolutionizes Consumer Experiences with Game-Changing mmWave Technology” more stocks inside…. - The Globe and Mail

Oct 15, 2024
pulisher
Oct 15, 2024

Rani Therapeutics Holdings Inc [RANI] is -4.22% lower this YTD. Is it still time to buy? - The DBT News

Oct 15, 2024
pulisher
Oct 15, 2024

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants - StockTitan

Oct 15, 2024
pulisher
Oct 15, 2024

3 Penny Stocks to Watch Now, 10/15/24 - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 15, 2024
pulisher
Oct 15, 2024

Ubiquiti Inc. (NYSE:UI) Shares Sold by Dimensional Fund Advisors LP - Defense World

Oct 15, 2024
pulisher
Oct 14, 2024

Rani Therapeutics Holdings Inc (RANI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Rani Therapeutics Holdings Inc (NASDAQ:RANI) stock crossing the finish line today - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 14, 2024
pulisher
Oct 14, 2024

Marshall Wace LLP Buys New Shares in Security National Financial Co. (NASDAQ:SNFCA) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Marshall Wace LLP Invests $81,000 in Design Therapeutics, Inc. (NASDAQ:DSGN) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Marshall Wace LLP Buys New Holdings in Hanesbrands Inc. (NYSE:HBI) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Investors bid Relief Therapeutics Holding (VTX:RLF) up CHF20m despite increasing losses YoY, taking five-year CAGR to 55% - Yahoo Finance

Oct 14, 2024
pulisher
Oct 13, 2024

Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics - Yahoo! Voices

Oct 13, 2024
pulisher
Oct 13, 2024

Walgreens: A New Risk Just Emerged for the Stock - Yahoo! Voices

Oct 13, 2024

Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Rani Therapeutics Holdings Inc-Aktie (RANI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Quiroga Cortes Isidoro Alfonso
10% Owner
Nov 24 '23
Sale
2.01
5,265,165
10,582,982
8,400
South Cone Investments Limited
10% Owner
Nov 24 '23
Buy
2.01
5,265,165
10,582,982
12,131,554
Imran Talat
Chief Executive Officer
Dec 06 '23
Buy
2.27
10,000
22,700
484,455
Imran Talat
Chief Executive Officer
Dec 04 '23
Buy
2.57
5,000
12,850
474,455
Imran Talat
Chief Executive Officer
Nov 29 '23
Buy
2.05
20,000
41,000
469,455
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):